• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

雌三醇替代疗法对更年期女性的疗效与安全性

Efficacy and safety of estriol replacement therapy for climacteric women.

作者信息

Yang T S, Tsan S H, Chang S P, Ng H T

机构信息

Department of Obstetrics and Gynecology, Veterans General Hospital-Taipei, Taiwan, R.O.C.

出版信息

Zhonghua Yi Xue Za Zhi (Taipei). 1995 May;55(5):386-91.

PMID:7641124
Abstract

BACKGROUND

As an estrogen derivative, estriol is rather effective in the relief of climacteric symptoms due to estrogen deficiency. When given one dose a day, it will not provoke endometrial proliferation and shedding. Thus, it is suitable for postmenopausal women who no longer want to have uterine bleeding and for those with comparatively higher risk of endometrial hyperplasia. In the aspect of postmenopausal osteoporosis, the prevention of further bone loss due to estrogen deficiency is also important and to be evaluated.

METHODS

We collected 20 patients, aged 44-62 years, who had undergone either natural or surgical menopause and were treated with estriol succinate (Synapause; Organon; Holland 2 mg/tab) 2 mg/day for 2 years, with relief of climacteric symptoms evaluated after the first 3 months of treatment. Bone mineral density (BMD) of lumbar spine was measured using quantitative computed tomography (QCT) after one and two years of treatment, respectively.

RESULTS

Estriol was very effective in the improvement of major subjective climacteric complaints in 86% of patients, especially hot flush and insomnia within 3 months. The atrophic genital changes caused by estrogen deficiency were also improved satisfactorily. No subjective symptoms induced by the therapy were seen. The rate of uterine bleeding was low, complained by only one patient. However, our study did not show the preventive effect of estriol against osteoporosis.

CONCLUSIONS

Estriol can be a safe and effective alternative in the relief of climacteric symptoms for postmenopausal women, but it cannot prevent the bone loss.

摘要

背景

作为一种雌激素衍生物,雌三醇在缓解因雌激素缺乏引起的更年期症状方面相当有效。每天服用一剂时,它不会引发子宫内膜增殖和脱落。因此,它适用于不再希望出现子宫出血的绝经后妇女以及子宫内膜增生风险相对较高的妇女。在绝经后骨质疏松方面,预防因雌激素缺乏导致的进一步骨质流失也很重要,有待评估。

方法

我们收集了20名年龄在44 - 62岁之间的患者,她们经历了自然绝经或手术绝经,并接受了琥珀酸雌三醇(Synapause;欧加农公司;荷兰,2毫克/片)治疗,每天2毫克,持续2年,在治疗的前3个月后评估更年期症状的缓解情况。分别在治疗1年和2年后,使用定量计算机断层扫描(QCT)测量腰椎的骨密度(BMD)。

结果

雌三醇在改善86%患者的主要主观更年期症状方面非常有效,尤其是在3个月内缓解潮热和失眠。雌激素缺乏引起的生殖器萎缩变化也得到了令人满意的改善。未观察到治疗引起的主观症状。子宫出血发生率较低,仅有一名患者抱怨。然而,我们的研究未显示雌三醇对骨质疏松的预防作用。

结论

雌三醇可以是绝经后妇女缓解更年期症状的一种安全有效的替代药物,但它不能预防骨质流失。

相似文献

1
Efficacy and safety of estriol replacement therapy for climacteric women.雌三醇替代疗法对更年期女性的疗效与安全性
Zhonghua Yi Xue Za Zhi (Taipei). 1995 May;55(5):386-91.
2
Results of a 5 years prospective study of estriol succinate treatment in patients with climacteric complaints.对患有更年期症状的患者进行琥珀酸雌三醇治疗的5年前瞻性研究结果。
Horm Metab Res. 1987 Nov;19(11):579-84. doi: 10.1055/s-2007-1011886.
3
Effect of combined oral estrogen/progestogen preparation (Kliogest) on bone mineral density, plasma lipids and postmenopausal symptoms in HRT-naïve Thai women.联合口服雌激素/孕激素制剂(克利奥杰斯特)对未接受激素替代疗法的泰国女性骨密度、血脂及绝经后症状的影响。
Acta Obstet Gynecol Scand. 2003 Sep;82(9):857-66.
4
Efficacy and safety of oral estriol for managing postmenopausal symptoms.
Maturitas. 2000 Feb 15;34(2):169-77. doi: 10.1016/s0378-5122(99)00108-5.
5
Salmon calcitonin plus intravaginal estriol: an effective treatment for the menopause.鲑鱼降钙素加阴道用雌三醇:一种治疗更年期的有效方法。
Maturitas. 1996 May;24(1-2):83-90. doi: 10.1016/0378-5122(95)01022-x.
6
Effect of estriol on bone loss in postmenopausal Japanese women: a multicenter prospective open study.雌三醇对绝经后日本女性骨质流失的影响:一项多中心前瞻性开放性研究。
J Obstet Gynaecol Res. 1996 Jun;22(3):259-65. doi: 10.1111/j.1447-0756.1996.tb00976.x.
7
Estrogen-progestogen replacement therapy in postmenopausal women--is 1 mg estradiolvalerate sufficient to maintain axial trabecular bone density?绝经后女性的雌激素 - 孕激素替代疗法——1毫克戊酸雌二醇足以维持轴向小梁骨密度吗?
Int J Clin Pharmacol Ther. 1994 May;32(5):254-8.
8
Superior compliance and efficacy of continuous combined oral estrogen-progestogen replacement therapy in postmenopausal women.连续联合口服雌激素 - 孕激素替代疗法在绝经后女性中的依从性和疗效更佳。
Am J Obstet Gynecol. 1995 Nov;173(5):1446-51. doi: 10.1016/0002-9378(95)90631-2.
9
[Effect of Kliogest on bone metabolism, bone mineral density and quality of life in postmenopausal patients].[克龄蒙对绝经后患者骨代谢、骨密度及生活质量的影响]
Vnitr Lek. 1998 Aug;44(8):464-8.
10
Low-dose, vaginally administered estrogens may enhance local benefits of systemic therapy in the treatment of urogenital atrophy in postmenopausal women on hormone therapy.低剂量经阴道给药的雌激素可能会增强全身治疗对接受激素治疗的绝经后女性泌尿生殖系统萎缩的局部治疗效果。
Maturitas. 2005 Feb 14;50(2):98-104. doi: 10.1016/j.maturitas.2004.04.007.

引用本文的文献

1
Sleep Disturbances Across a Woman's Lifespan: What Is the Role of Reproductive Hormones?女性一生中的睡眠障碍:生殖激素起什么作用?
J Endocr Soc. 2023 Mar 15;7(5):bvad036. doi: 10.1210/jendso/bvad036. eCollection 2023 Mar 6.
2
Off-label use of hormones as an antiaging strategy: a review.激素的非标签使用作为一种抗衰老策略:综述
Clin Interv Aging. 2014 Jul 23;9:1175-86. doi: 10.2147/CIA.S48918. eCollection 2014.